Report Detail
Global Biosimulation Technology Market Size, Status and Forecast 2019-2025
- RnM3472435 |
- 10 July, 2019 |
- Global |
- 93 Pages |
- QYResearch |
- Other
Biosimulation techonlogy is a mathematical simulation of biological process in which computer aided programs are used for the simulation of biological processes and systems. It is also known as model-based drug development that has ability to make data-driven decisions at all stages of drug development through a quantitative framework. Biosimulation is a promising technology that especially used in pharmaceutical research to improve the drug discovery and development cycle of a drug.
In 2018, the global Biosimulation Technology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Biosimulation Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosimulation Technology development in United States, Europe and China.
The key players covered in this study
Certara USA
Simulation Plus
Dassault Systèmes
Schrodinger
Advanced Chemistry Development
Chemical Computing Group
Entelos
Genedata
Physiomics
Rhenovia Pharma
Market segment by Type, the product can be split into
Software
Service
Market segment by Application, split into
Drug development
Drug discovery
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Biosimulation Technology status, future forecast, growth opportunity, key market and key players.
To present the Biosimulation Technology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Biosimulation Technology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Biosimulation Technology Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Software
- 1.4.3 Service
- 1.5 Market by Application
- 1.5.1 Global Biosimulation Technology Market Share by Application (2014-2025)
- 1.5.2 Drug development
- 1.5.3 Drug discovery
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Biosimulation Technology Market Size
- 2.2 Biosimulation Technology Growth Trends by Regions
- 2.2.1 Biosimulation Technology Market Size by Regions (2014-2025)
- 2.2.2 Biosimulation Technology Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Biosimulation Technology Market Size by Manufacturers
- 3.1.1 Global Biosimulation Technology Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Biosimulation Technology Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Biosimulation Technology Market Concentration Ratio (CR5 and HHI)
- 3.2 Biosimulation Technology Key Players Head office and Area Served
- 3.3 Key Players Biosimulation Technology Product/Solution/Service
- 3.4 Date of Enter into Biosimulation Technology Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Biosimulation Technology Market Size by Type (2014-2019)
- 4.2 Global Biosimulation Technology Market Size by Application (2014-2019)
5 United States
- 5.1 United States Biosimulation Technology Market Size (2014-2019)
- 5.2 Biosimulation Technology Key Players in United States
- 5.3 United States Biosimulation Technology Market Size by Type
- 5.4 United States Biosimulation Technology Market Size by Application
6 Europe
- 6.1 Europe Biosimulation Technology Market Size (2014-2019)
- 6.2 Biosimulation Technology Key Players in Europe
- 6.3 Europe Biosimulation Technology Market Size by Type
- 6.4 Europe Biosimulation Technology Market Size by Application
7 China
- 7.1 China Biosimulation Technology Market Size (2014-2019)
- 7.2 Biosimulation Technology Key Players in China
- 7.3 China Biosimulation Technology Market Size by Type
- 7.4 China Biosimulation Technology Market Size by Application
8 Japan
- 8.1 Japan Biosimulation Technology Market Size (2014-2019)
- 8.2 Biosimulation Technology Key Players in Japan
- 8.3 Japan Biosimulation Technology Market Size by Type
- 8.4 Japan Biosimulation Technology Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Biosimulation Technology Market Size (2014-2019)
- 9.2 Biosimulation Technology Key Players in Southeast Asia
- 9.3 Southeast Asia Biosimulation Technology Market Size by Type
- 9.4 Southeast Asia Biosimulation Technology Market Size by Application
10 India
- 10.1 India Biosimulation Technology Market Size (2014-2019)
- 10.2 Biosimulation Technology Key Players in India
- 10.3 India Biosimulation Technology Market Size by Type
- 10.4 India Biosimulation Technology Market Size by Application
11 Central & South America
- 11.1 Central & South America Biosimulation Technology Market Size (2014-2019)
- 11.2 Biosimulation Technology Key Players in Central & South America
- 11.3 Central & South America Biosimulation Technology Market Size by Type
- 11.4 Central & South America Biosimulation Technology Market Size by Application
12 International Players Profiles
- 12.1 Certara USA
- 12.1.1 Certara USA Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Biosimulation Technology Introduction
- 12.1.4 Certara USA Revenue in Biosimulation Technology Business (2014-2019)
- 12.1.5 Certara USA Recent Development
- 12.2 Simulation Plus
- 12.2.1 Simulation Plus Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Biosimulation Technology Introduction
- 12.2.4 Simulation Plus Revenue in Biosimulation Technology Business (2014-2019)
- 12.2.5 Simulation Plus Recent Development
- 12.3 Dassault Systèmes
- 12.3.1 Dassault Systèmes Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Biosimulation Technology Introduction
- 12.3.4 Dassault Systèmes Revenue in Biosimulation Technology Business (2014-2019)
- 12.3.5 Dassault Systèmes Recent Development
- 12.4 Schrodinger
- 12.4.1 Schrodinger Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Biosimulation Technology Introduction
- 12.4.4 Schrodinger Revenue in Biosimulation Technology Business (2014-2019)
- 12.4.5 Schrodinger Recent Development
- 12.5 Advanced Chemistry Development
- 12.5.1 Advanced Chemistry Development Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Biosimulation Technology Introduction
- 12.5.4 Advanced Chemistry Development Revenue in Biosimulation Technology Business (2014-2019)
- 12.5.5 Advanced Chemistry Development Recent Development
- 12.6 Chemical Computing Group
- 12.6.1 Chemical Computing Group Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Biosimulation Technology Introduction
- 12.6.4 Chemical Computing Group Revenue in Biosimulation Technology Business (2014-2019)
- 12.6.5 Chemical Computing Group Recent Development
- 12.7 Entelos
- 12.7.1 Entelos Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Biosimulation Technology Introduction
- 12.7.4 Entelos Revenue in Biosimulation Technology Business (2014-2019)
- 12.7.5 Entelos Recent Development
- 12.8 Genedata
- 12.8.1 Genedata Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Biosimulation Technology Introduction
- 12.8.4 Genedata Revenue in Biosimulation Technology Business (2014-2019)
- 12.8.5 Genedata Recent Development
- 12.9 Physiomics
- 12.9.1 Physiomics Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Biosimulation Technology Introduction
- 12.9.4 Physiomics Revenue in Biosimulation Technology Business (2014-2019)
- 12.9.5 Physiomics Recent Development
- 12.10 Rhenovia Pharma
- 12.10.1 Rhenovia Pharma Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Biosimulation Technology Introduction
- 12.10.4 Rhenovia Pharma Revenue in Biosimulation Technology Business (2014-2019)
- 12.10.5 Rhenovia Pharma Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Biosimulation Technology. Industry analysis & Market Report on Biosimulation Technology is a syndicated market report, published as Global Biosimulation Technology Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Biosimulation Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
